Get the Stockscreener App
1.0075
0.75%
0.0075
After Hours:
1.02
0.0125
+1.24%
Sunshine Biopharma Inc stock is traded at $1.0075, with a volume of 17,190.
It is up +0.75% in the last 24 hours and down -9.23% over the past month.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
See More
Previous Close:
$1.00
Open:
$1
24h Volume:
17,190
Relative Volume:
0.48
Market Cap:
$4.94M
Revenue:
$36.31M
Net Income/Loss:
$-5.98M
P/E Ratio:
-0.6785
EPS:
-1.4848
Net Cash Flow:
$-6.17M
1W Performance:
-3.12%
1M Performance:
-9.23%
6M Performance:
-54.20%
1Y Performance:
-17.42%
1-Day Range:
$0.983
$1.0115
1-Week Range:
$0.953
$1.04
52-Week Range:
$0.953
$2.43
Sunshine Biopharma Inc Stock (SBFM) Company Profile
Name
Sunshine Biopharma Inc
Sector
Phone
954-330-0684
Address
333 LAS OLAS WAY, FORT LAUDERDALE
Compare SBFM vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SBFM
Sunshine Biopharma Inc
|
1.0075 | 4.91M | 36.31M | -5.98M | -6.17M | -1.4848 |
TAK
Takeda Pharmaceutical Co Adr
|
17.78 | 56.39B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
119.04 | 50.78B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.59 | 43.02B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.26 | 36.81B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
580.50 | 25.31B | 3.18B | 1.33B | 1.04B | 27.90 |
Sunshine Biopharma Inc Stock (SBFM) Latest News
SBFM Director Natan David Acquires 100K Shares – April 15, 2026 - Meyka
Director Natan David receives 100,000 SBFM shares in stock award - Stock Titan
Returns Recap: What is Sunshine Biopharma Incs valuation compared to sector2026 Big Picture & Low Risk Investment Opportunities - baoquankhu1.vn
US Market Recap: Is Sunshine Biopharma Incs ROE strong enough2026 Snapshot & Weekly Setup with High ROI Potential - baoquankhu1.vn
Smart Money: What is Sunshine Biopharma Incs valuation compared to sectorTrade Exit Report & Verified Momentum Stock Alerts - baoquankhu1.vn
Sunshine Biopharma Posts Modest 2025 Revenue Growth and Tightens Costs to Pursue Profitability - TipRanks
Sunshine Biopharma (NASDAQ: SBFM) details 2025 results and cost cuts - Stock Titan
SBFM Reports Increased Revenue and Outlines Future Growth Plans - GuruFocus
Sunshine Biopharma (SBFM) Aims for Cost Reductions to Enhance Pr - GuruFocus
Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year - ACCESS Newswire
Sunshine Biopharma launched nine new drugs as 2025 sales hit $36.3M - Stock Titan
Sunshine Biopharma Inc. 2025 Annual Report: Generic Drug Portfolio, Proprietary Oncology & Antiviral Developments, and Corporate Strategy - Minichart
Sunshine Biopharma Inc reports results for the quarter ended December 31Earnings Summary - TradingView — Track All Markets
Sunshine Biopharma (NASDAQ: SBFM) 2025 revenue reaches $36.3M - Stock Titan
Sunshine Biopharma 2025 10-K: $36.3M Revenue, $(1.44) EPS - TradingView — Track All Markets
Sunshine Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Aug Reactions: Is Sunshine Biopharma Inc Equity Warrant benefiting from interest rate changesQuarterly Performance Summary & High Accuracy Investment Entry Signals - baoquankhu1.vn
Sunshine Biopharma Delays Annual SEC Filing - TipRanks
[NT 10-K] Sunshine Biopharma Inc. SEC Filing - Stock Titan
SBFM PE Ratio & Valuation, Is SBFM Overvalued - Intellectia AI
Aug Wrap: Does Sunshine Biopharma Inc Equity Warrant stock have upside surprise potential - baoquankhu1.vn
Bear Alert: What are the future prospects of Sunshine Biopharma Inc Equity Warrant2026 Volume Leaders & Safe Capital Investment Plans - baoquankhu1.vn
Smart Money: Is Sunshine Biopharma Inc Equity Warrant benefiting from interest rate changesTrend Reversal & Weekly Top Gainers Alerts - baoquankhu1.vn
Sunshine Biopharma Inc expected to post a loss of 27 cents a shareEarnings Preview - TradingView
Guidance Update: What is the cash position of Sunshine Biopharma Inc Equity Warrant2026 Retail & Low Risk Entry Point Tips - baoquankhu1.vn
Sunshine Biopharma, Inc.: Fundamental Analysis and Financial Ratings | | US8677811064 - marketscreener.com
Revenue per share of Sunshine Biopharma Inc. – NASDAQ:SBFMW - TradingView
SBFM Forecast, Price Target & Analyst Ratings | SUNSHINE BIOPHARMA INC (NASDAQ:SBFM) - ChartMill
Sunshine Biopharma's March Milestone: A Strategic Financial Review () - aktiencheck.de
Returns Recap: What are the future prospects of Sunshine Biopharma Inc Equity Warrant2026 Top Gainers & Safe Swing Trade Setups - baoquankhu1.vn
Sunshine Biopharma Engages Aegis for Warrant Solicitation - TipRanks
Sunshine Biopharma engages Aegis for three-month warrant solicitation, 10% fee on proceeds - TradingView
Sunshine Biopharma (SBFM) taps Aegis to solicit exercises of outstanding warrants - Stock Titan
Risk Check: Will Sunshine Biopharma Inc outperform its industry peersTrade Analysis Summary & Community Verified Trade Signals - baoquankhu1.vn
Sunshine Biopharma (SBFM) Board May Effect Up-to 1-for-10 Reverse Split - Stock Titan
SBFM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Aug Gainers: Is Sunshine Biopharma Incs ROE strong enoughJuly 2025 Retail & Weekly High Momentum Picks - baoquankhu1.vn
SBFM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Aug Retail: Is Sunshine Biopharma Inc Equity Warrant affected by consumer sentimentWeekly Stock Recap & Capital Efficiency Focused Strategies - baoquankhu1.vn
Fund Flows: What is the Moat Score of Sunshine Biopharma IncTrade Volume Report & Entry and Exit Point Strategies - baoquankhu1.vn
Market Review: What is Sunshine Biopharma Incs valuation compared to sector2025 Historical Comparison & Expert Verified Movement Alerts - baoquankhu1.vn
SBFMW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
SBFM (Sunshine Biopharma) Total Inventories : $14.06 Mil (As of Sep. 2025) - GuruFocus
Sunshine Biopharma board authorized to consider reverse stock split By Investing.com - Investing.com Nigeria
Sunshine Biopharma board authorized to consider reverse stock split - Investing.com
Sunshine Biopharma Shareholders Approve Potential Reverse Stock Split - TipRanks
Sunshine Biopharma (SBFM) majority holder clears path for up to 1-for-10 reverse split - Stock Titan
Weekly Earnings: Will Sunshine Biopharma Inc. outperform its industry peersDollar Strength & High Win Rate Trade Alerts - mfd.ru
MSN Money - MSN
Is Sunshine Biopharma Inc. Equity Warrant benefiting from innovation trends2025 Buyback Activity & Verified Chart Pattern Signals - mfd.ru
SBFM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Sunshine Biopharma Inc Stock (SBFM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):